Structure-Based Virtual Screening to Identify Negative Allosteric Modulators of NMDA
CONCLUSION: The product of the study are compounds which have been validated through pharmacophore and score-based screening and MD simulation techniques to be allosterically inhibiting NMDA receptors and with favorable pharmacokinetic profile are likely to be therapeutic agents ready for in-vitro and in-vivo testing.PMID:35249502 | DOI:10.2174/1573406418666220304224150
Source: Medicinal Chemistry - Category: Chemistry Authors: Zaid Anis Sherwani Ruqaiya Khalil Mohammad Nur-E-Alam Sarfaraz Ahmed Zaheer Ul-Haq Source Type: research
More News: Alzheimer's | Brain | Chemistry | Databases & Libraries | Huntington's Disease | Learning | Neurology | Parkinson's Disease | Stroke | Study | Universities & Medical Training